Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2326 to 2340 of 8234 results

  1. Minimally invasive surgical evacuation of intracerebral haemorrhage using endoscopic assisted clot aspiration

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  2. Thromboaspiration for Intermediate risk Pulmonary Embolism

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  3. Electrosurgery (diathermy and coblation) for tonsillectomy

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  4. Extracorporeal shockwave therapy for refractory plantar fasciitis

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  5. Automated percutaneous mechanical lumbar discectomy

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  6. Miniature lens system implantation for advanced age-related macular degeneration

    Topic prioritisation

    Interventional procedures guidance
    Topic prioritisation

  7. Trastuzumab deruxtecan for neoadjuvant treatment of HER2-positive high-risk early breast cancer [ID6620]

    Awaiting development Reference number: GID-TA11403 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  8. Oveporexton for treating type 1 narcolepsy [ID6622]

    Awaiting development Reference number: GID-TA11820 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  9. Beremagene geperpavec for treating skin wounds associated with dystrophic epidermolysis bullosa [ID3959]

    In development Reference number: GID-TA10868 Expected publication date:  15 July 2026

    Technology appraisal guidance
    In development

  10. Zimislecel for treating type 1 diabetes in people 12 years and over with impaired hypoglycaemic awareness and severe hypoglycaemia [ID6624]

    Awaiting development Reference number: GID-TA11816 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  11. Talquetamab with daratumumab for treating relapsed or refractory multiple myeloma after 1 or more lines of treatment including a proteasome inhibitor and lenalidomide [ID6625]

    Awaiting development Reference number: GID-TA11815 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  12. Psoriasis: assessment and management (CG153)

    In development Reference number: GID-NG10448 Expected publication date: TBC

    NICE guideline
    In development

  13. Technologies to improve the detection of endometrial cancer

    Topic prioritisation

    Health technology evaluations
    Topic prioritisation

  14. Semaglutide for preventing major cardiovascular events in people with cardiovascular disease and overweight or obesity [ID6441]

    In development Reference number: GID-TA11544 Expected publication date:  14 May 2026

    Technology appraisal guidance
    In development

  15. Trastuzumab deruxtecan for adjuvant treatment of high-risk HER2-positive residual invasive breast cancer after neoadjuvant chemotherapy [ID6509]

    In development Reference number: GID-TA11658 Expected publication date: TBC

    Technology appraisal guidance
    In development